The epidemiology of psoriatic arthritis in Israel - a population-based study
- PMID: 29329596
- PMCID: PMC5795280
- DOI: 10.1186/s13075-017-1497-4
The epidemiology of psoriatic arthritis in Israel - a population-based study
Abstract
Background: There is limited information on the epidemiology of psoriatic arthritis (PsA) in general and in Middle Eastern populations in particular. The aims of this study were to estimate the prevalence and incidence rates of PsA and their temporal trends in the general population in Israel.
Methods: In this study, a cohort of adult patients with PsA was derived from the database of Clalit Health Services (CHS), Israel's largest health fund, with over 4.4 million members. The crude and age- and sex-standardized prevalence and incidence rates of PsA from 2006 to 2015 in the general population were calculated. The variation in PsA prevalence was assessed in relation to several demographic factors.
Results: Among the 2,931,199 individuals aged 18 years and older registered in the CHS database in 2015, 4490 patients had a diagnosis of PsA (322 incident cases), resulting in overall crude prevalence and incidence rates of 0.153% (95% CI 0.149%, 0.158%) and 10.9 (95% CI 9.8, 12.3) per 100,000 population, respectively. The reported prevalence of PsA in Israel has doubled between 2006 and 2015 (from 0.073% to 0.153%). In contrast, the global incidence rate remained stable, with a gradual increase in incidence among individuals aged 51 to 70 years. PsA is associated with Jewish ethnicity, high socioeconomic status, and higher body mass index.
Conclusions: The prevalence and incidence of PsA in Israel are within the range of previous estimates from Southern European populations. An increase in the reported prevalence of PsA was observed over the past decade in the general population in Israel.
Keywords: Epidemiology; Middle East; Psoriasis; Psoriatic arthritis; Spondyloarthritis.
Conflict of interest statement
Ethics approval and consent to participate
The study was approved by the research ethics board of Carmel Medical Center. All data in this study were anonymous to the investigators; therefore, no consent was required.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
Similar articles
-
Epidemiological trends in psoriatic arthritis: a comprehensive population-based study.Arthritis Res Ther. 2024 May 27;26(1):108. doi: 10.1186/s13075-024-03339-0. Arthritis Res Ther. 2024. PMID: 38802958 Free PMC article.
-
Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study.Arthritis Res Ther. 2017 May 18;19(1):102. doi: 10.1186/s13075-017-1315-z. Arthritis Res Ther. 2017. PMID: 28521824 Free PMC article.
-
Epidemiology and Medication Pattern Change of Psoriatic Diseases in Taiwan from 2000 to 2013: A Nationwide, Population-based Cohort Study.J Rheumatol. 2018 Mar;45(3):385-392. doi: 10.3899/jrheum.170516. Epub 2018 Jan 15. J Rheumatol. 2018. PMID: 29335350
-
Incidence and prevalence of psoriatic arthritis: a systematic review.J Rheumatol. 2008 Jul;35(7):1354-8. Epub 2008 May 1. J Rheumatol. 2008. PMID: 18464305
-
Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies.J Am Acad Dermatol. 2019 Jan;80(1):251-265.e19. doi: 10.1016/j.jaad.2018.06.027. Epub 2018 Jun 19. J Am Acad Dermatol. 2019. PMID: 29928910
Cited by
-
Costs and Health Outcomes Associated with Tofacitinib Treatment for Active Psoriatic Arthritis in the United States.J Manag Care Spec Pharm. 2020 Aug;26(8):1027-1038. doi: 10.18553/jmcp.2020.19319. Epub 2020 Apr 20. J Manag Care Spec Pharm. 2020. PMID: 32308099 Free PMC article.
-
The Risk of Herpes Zoster Events in Patients with Spondyloarthritis and the Effect of BNT162b2 mRNA COVID-19 Vaccine.Vaccines (Basel). 2024 Jan 15;12(1):85. doi: 10.3390/vaccines12010085. Vaccines (Basel). 2024. PMID: 38250898 Free PMC article.
-
Late-Onset and Elderly Psoriatic Arthritis: Clinical Aspects and Management.Drugs Aging. 2019 Oct;36(10):909-925. doi: 10.1007/s40266-019-00688-3. Drugs Aging. 2019. PMID: 31250280 Review.
-
The Epidemiology of Psoriatic Arthritis Over Five Decades: A Population-Based Study.Arthritis Rheumatol. 2021 Oct;73(10):1878-1885. doi: 10.1002/art.41741. Epub 2021 Aug 14. Arthritis Rheumatol. 2021. PMID: 33779070 Free PMC article.
-
Paradoxical Effects of Depression on Psoriatic Arthritis Outcomes in a Combined Psoriasis-Psoriatic Arthritis Center.J Psoriasis Psoriatic Arthritis. 2023 Oct;8(4):134-140. doi: 10.1177/24755303231186405. Epub 2023 Jun 26. J Psoriasis Psoriatic Arthritis. 2023. PMID: 38188536 Free PMC article.
References
-
- Alamanos Y, Voulgari P, Drosos A. Incidence and prevalence of psoriatic arthritis: a systematic review. J Rheumatol. 2008;35:1354–8. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous